Understanding Harlequin Ichthyosis: Causes, Symptoms, and Management
- Abagail Walters

- Jun 2, 2024
- 3 min read

Harlequin ichthyosis is a rare and severe genetic skin disorder characterized by thick, scaly skin that can cause significant medical complications. This condition is part of a group of disorders known as ichthyoses, which are marked by dry, scaly skin.
Causes:
Harlequin ichthyosis is caused by mutations in the ABCA12 gene, which is crucial for the normal development of the skin. This gene provides instructions for making a protein essential for transporting lipids in the outermost layer of the skin. When this protein is not functional, skin cells develop abnormally, leading to the thick, hard scales characteristic of the disorder (National Organization for Rare Disorders, 2023).
Symptoms:
Babies with harlequin ichthyosis are often born with thick, hard skin covering most of their bodies. This skin is divided into large, diamond-shaped plates separated by deep cracks. These abnormalities can lead to a range of symptoms and complications:
Physical Appearance: The thickened skin plates can distort facial features and limit movement of the arms and legs.

Respiratory Issues: Restricted chest expansion can cause breathing difficulties.
Feeding Difficulties: Tight skin around the mouth can make breastfeeding or bottle-feeding challenging.
Temperature Regulation: The thick skin can impair the body’s ability to regulate temperature.
Infection: Cracks in the skin increase the risk of bacterial infections.
Statistics:
Prevalence: Harlequin ichthyosis is extremely rare, affecting approximately 1 in 300,000 births (National Institutes of Health, 2023).
Survival Rates: Historically, the prognosis for infants with harlequin ichthyosis was poor, with many dying shortly after birth due to complications such as infection and dehydration. However, advances in neonatal care have significantly improved survival rates. Today, with proper medical care, many affected individuals can survive into adulthood (National Organization for Rare Disorders, 2023).
Genetic Basis: Harlequin ichthyosis is an autosomal recessive disorder, meaning that both parents must carry one copy of the mutated gene to pass the condition on to their child. Genetic counseling is recommended for families with a history of the disorder (Genetics Home Reference, 2023).
Management:
Managing Harlequin ichthyosis involves a multidisciplinary approach to address the various complications associated with the disorder. Early intervention and intensive care are crucial, particularly for newborns.
Skin Care: Regularly apply moisturizing creams and ointments to keep the skin soft and pliable. Products containing urea or alpha-hydroxy acids are often recommended to help exfoliate the skin (Mayo Clinic, 2023).
Infection Control: Prompt treatment of skin infections with antibiotics.
Hydration: Ensuring adequate fluid intake to prevent dehydration.
Temperature Control: Maintaining an appropriate environment to help with temperature regulation.
Surgical Interventions: In some cases, surgical procedures may be necessary to relieve tight skin around the eyes and mouth.
Advances in Treatment:

Recent advances in medical research and treatment options have significantly improved the prognosis for individuals with harlequin ichthyosis. Key developments include:
Gene Therapy: Research is ongoing to explore the potential of gene therapy to correct the underlying genetic defect in harlequin ichthyosis. While still in the experimental stages, this approach holds promise for future treatments (Journal of Investigative Dermatology, 2023).
Targeted Therapies: New medications that target specific pathways involved in skin cell development and inflammation are being investigated. These therapies aim to reduce the severity of symptoms and improve skin condition (American Academy of Dermatology, 2023).
Long-Term Outlook:
With advances in medical care, individuals with harlequin ichthyosis are living longer and healthier lives. Early and aggressive treatment can significantly improve the quality of life and reduce the risk of severe complications. Regular follow-ups with dermatologists and other specialists are essential to monitor the condition and manage symptoms effectively (American Academy of Dermatology, 2023).
Conclusion:
Harlequin ichthyosis is a challenging condition that requires comprehensive medical management. Understanding the genetic basis and associated complications of this disorder is crucial for providing effective care. Continued research and advancements in medical treatment offer hope for improved outcomes for those affected by Harlequin ichthyosis.
Citations:
Images:
Harlequin ichthyosis Baby Diagram: Photo Credit due to Cleveland Clinic, asked for permission to use photo, no changes were made to the image.
Harlequin Ichthyosis Skin Diagram: Photo Credit due to News Medical Life Sciences, asked for permission to use photo, no changes were made to the image.
3D model of Harlequin Ichthyosis Skin: Photo Credit Due to the Journal of Clinical Investigations, asked for permission to use photo, no changes were made to the image.
Sources:
National Organization for Rare Disorders. (NORD). https://rarediseases.org/rare-diseases/ichthyosis-harlequin-type/
Mayo Clinic. https://my.clevelandclinic.org/health/diseases/harlequin-ichthyosis
American Academy of Dermatology. https://www.aad.org/skinserious/stories-jennie-riley
National Institutes of Health. https://rarediseases.info.nih.gov/diseases/6568/harlequin-ichthyosis
Genetics Home Reference. https://medlineplus.gov/genetics/condition/harlequin-ichthyosis/
Journal of Investigative Dermatology. https://www.jidonline.org/article/S0022-202X(15)30333-X/fulltext
842 views


Nice :)